FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,871 | -85.9% | 52,000 | +206.0% | 0.00% | -86.4% |
| Q1 2023 | $317,145 | +713.2% | 16,996 | +353.8% | 0.02% | +450.0% |
| Q2 2022 | $39,000 | -71.1% | 3,745 | -71.8% | 0.00% | -60.0% |
| Q3 2021 | $135,000 | -41.8% | 13,296 | +98.8% | 0.01% | -54.5% |
| Q1 2021 | $232,000 | +91.7% | 6,687 | +125.5% | 0.02% | +57.1% |
| Q3 2020 | $121,000 | +68.1% | 2,966 | +66.3% | 0.01% | +40.0% |
| Q2 2020 | $72,000 | -48.9% | 1,784 | -45.9% | 0.01% | -28.6% |
| Q4 2019 | $141,000 | +171.2% | 3,297 | +130.6% | 0.01% | +180.0% |
| Q3 2019 | $52,000 | +13.0% | 1,430 | +86.2% | 0.01% | +66.7% |
| Q3 2018 | $46,000 | -37.8% | 768 | -35.2% | 0.00% | -40.0% |
| Q2 2018 | $74,000 | +7300.0% | 1,185 | +3385.3% | 0.01% | – |
| Q3 2017 | $1,000 | -99.2% | 34 | -99.1% | 0.00% | -100.0% |
| Q2 2017 | $128,000 | +23.1% | 3,987 | -21.3% | 0.01% | 0.0% |
| Q3 2016 | $104,000 | -36.6% | 5,068 | -49.3% | 0.01% | -29.4% |
| Q2 2016 | $164,000 | – | 9,994 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |